86208-07-3

Upstream product

• 51052-79-0 3-(4-piperidinyl)propionic acid hydrochloride 
• 4457-32-3 4-nitrobenzyl chloroformate 
• 131417-49-7 3-[1-(acetyl)-4-piperidinyl]propionic acid 

Downstream Products

• 849935-46-2 4-nitrobenzyl 4-{3-oxo-3-[3-(trifluoroacetyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl]propyl}piperidine-1-carboxylate 
• 849935-45-1 4-nitrobenzyl 4-[3-(2-acetyl-2,3,4,5-tetrahydro-1H-benzo[c]azepin-8-yl)-3-oxopropyl]piperidine-1-carboxylate 
• 849935-47-3 4-nitrobenzyl 4-[3-(4-formyl-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepin-7-yl)-3-oxopropyl]piperidine-1-carboxylate 
• 849935-44-0 4-nitrobenzyl 4-(3-chloro-3-oxopropyl)piperidine-1-carboxylate 

Relevant academic research and scientific papers

Novel acetylcholinesterase inhibitor as increasing agent on rhythmic bladder contractions: SAR of 8-{3-[1-(3-fluorobenzyl)piperidin-4-yl]propanoyl}- 1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one (TAK-802) and related compounds

As part of an on-going investigation to develop an increasing agent on rhythmic bladder contractions, 1-aryl-3-(1-benzylpiperidin-4-yl)propanones were synthesized and examined as noncarbamate acetylcholinesterase (AChE) inhibitors. Among compounds with va

TETRACYCLIC CONDENSED HETEROCYCLIC COMPOUNDS AND THEIR USE

A novel compound of the formula wherein Ar represents a tetracyclic fused heterocyclic group which may be substituted; R1 represents H or a hydrocarbon group which may be substituted; Y represents an amino or nitrogen-containing saturated heterocyclic gro